Pronota - Product Pipeline Analysis
Pronota NV (Pronota) is a developer of biomarker discovery, based in Belgium. It focuses on protein biomarkers for identification of candidates for drug development and diagnostic products for diagnosis and personalized treatment of diseases. The company’s products include cardio-rendal, pre-eclampsia, sepsis, and ovarian cancer. Its technologies include MASStermind, a protein biomarker discovery platform that enables the identification and relative quantitation of proteins; and MASSterclass, a mass spectrometry based antibody-free assay platform that provides contract assay development and biomarker screening services....
View full press release